Hepatitis Monthly

Published by: Kowsar

Serological Assay and Genotyping of Hepatitis C Virus in Infected Patients in Zanjan Province

Abdolreza Esmaeilzadeh 1 , 2 , * , Maryam Erfanmanesh 3 , Sousan Ghasemi 4 and Farzaneh Mohammadi 1
Authors Information
1 Department of Immunolory, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, IR Iran
2 Cancer Gene Therapy Research Center, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, IR Iran
3 Young Researchers Club, Zanjan Branch, Islamic Azad University, Zanjan, IR Iran
4 Medical Laboratory, Shaheed Beheshti General Hospital, Zanjan University of Medical Sciences, Zanjan, IR Iran
Article information
  • Hepatitis Monthly: September 01, 2014, 14 (9); e17323
  • Published Online: September 27, 2014
  • Article Type: Research Article
  • Received: January 1, 2014
  • Revised: March 22, 2014
  • Accepted: May 23, 2014
  • DOI: 10.5812/hepatmon.17323

To Cite: Esmaeilzadeh A, Erfanmanesh M, Ghasemi S, Mohammadi F. Serological Assay and Genotyping of Hepatitis C Virus in Infected Patients in Zanjan Province, Hepat Mon. 2014 ; 14(9):e17323. doi: 10.5812/hepatmon.17323.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Aalaei-Andabili SH, Behnava B, Salimi S, Sharafi H, Alavian SM. Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis. Hepat Mon. 2014; 14(3)[DOI][PubMed]
  • 2. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011; 17(2): 107-15[DOI][PubMed]
  • 3. Martin NK, Vickerman P, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M. Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol. 2011; 54(6): 1137-44[DOI][PubMed]
  • 4. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345(1): 41-52[DOI][PubMed]
  • 5. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005; 8(2): 84-90
  • 6. Piluso A, Giannini C, Fognani E, Gragnani L, Caini P, Monti M, et al. Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study. J Viral Hepat. 2013; 20(4)-14[DOI][PubMed]
  • 7. Aleman S, Rahbin N, Weiland O, Davidsdottir L, Hedenstierna M, Rose N, et al. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Clin Infect Dis. 2013; 57(2): 230-6[DOI][PubMed]
  • 8. Ziyaeyan M, Alborzi A, Jamalidoust M, Badiee P, Moeini M, Kadivar A. Prevalence of hepatitis C virus genotypes in chronic infected patients, southern Iran. Jundishapur J Microbiol. 2011; 4(3): 141-6
  • 9. Farnik H, Mihm U, Zeuzem S. Optimal therapy in genotype 1 patients. Liver Int. 2009; 29 Suppl 1: 23-30[DOI][PubMed]
  • 10. Daw MA, Elasifer HA, Dau AA, Agnan M. The role of hepatitis C virus genotyping in evaluating the efficacy of INF-based therapy used in treating hepatitis C infected patients in Libya. Virol Discov. 2013; 1(3): 1-8[DOI]
  • 11. Abuelhassan W. Hepatitis C virus infection in 2012 and beyond. South Afr J Epidemiol Infect. 2012; 27(3): 93-7
  • 12. Kamal SM. Hepatitis C genotype 4 therapy: increasing options and improving outcomes. Liver Int. 2009; 29 Suppl 1: 39-48[DOI][PubMed]
  • 13. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat. 2002; 9(5): 390-2[PubMed]
  • 14. Tajbakhsh E, Dosti A, Tajbakhsh S, Momeni M, Tajbakhsh F. Determination of hepatitis C virus genotypes among HCV positive patients in Shahrekord, Iran. Afr J Microbiol Res. 2011; 5(32): 5910-5[DOI]
  • 15. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014; 59(1): 318-27[DOI][PubMed]
  • 16. Doerrbecker J, Meuleman P, Kang J, Riebesehl N, Wilhelm C, Friesland M, et al. Thermostability of seven hepatitis C virus genotypes in vitro and in vivo. J Viral Hepat. 2013; 20(7): 478-85[DOI][PubMed]
  • 17. Shawa IT, Hopkins M. Evaluation of Hepatitis C Virus Genotyping Protocols for Use in a Diagnostic Setting. Int J Med Res. 2013; 1(1): 2-7[DOI]
  • 18. Sam SS, Steinmetz HB, Tsongalis GJ, Tafe LJ, Lefferts JA. Validation of a solid-phase electrochemical array for genotyping hepatitis C virus. Exp Mol Pathol. 2013; 95(1): 18-22[DOI][PubMed]
  • 19. Gonzalez V, Gomes-Fernandes M, Bascunana E, Casanovas S, Saludes V, Jordana-Lluch E, et al. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice. J Clin Virol. 2013; 58(1): 249-53[DOI][PubMed]
  • 20. Cenci M, Massi M, Alderisio M, De Soccio G, Recchia O. Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: an update and report of a new method of HCV genotyping. Anticancer Res. 2007; 27(2): 1219-22[PubMed]
  • 21. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000; 13(2): 223-35[PubMed]
  • 22. Hajia M, Amirzargar A, Khedmat H, Shahrokhi N, Farzanehkhah M, Ghorishi S, et al. Genotyping Pattern among Iranian HCV Positive Patients. Iran J Public Health. 2010; 39(2): 39-44[PubMed]
  • 23. Bae AS, Ku KS, Miller MD, Mo H, Svarovskaia ES. Allele-specific real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples. J Clin Microbiol. 2011; 49(9): 3168-74[DOI][PubMed]
  • 24. Nakatani SM, Santos CA, Riediger IN, Krieger MA, Duarte CA, do Carmo Debur M, et al. Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C. Virol J. 2011; 8: 459[DOI][PubMed]
  • 25. MirDavood O, Khadem AMH. Hepatitis c virus genotyping by melting curve analysis in west azerbaijan, northwest of IRAN. Hepat Mon. 2009; 9(2): 133-6
  • 26. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Nasseri S. Distribution of hepatitis C virus genotypes among azerbaijani patients in capital city of iran-tehran. Hepat Mon. 2013; 13(9)[DOI][PubMed]
  • 27. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013; 13(1)[DOI][PubMed]
  • 28. Zarkesh Esfahani SH, Kardi MT, Edalati M. Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study. Virol J. 2010; 7(69): 1-6
  • 29. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol. 2006; 78(5): 569-73[DOI][PubMed]
  • 30. Nguyen MH, Keeffe EB. Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Rev Gastroenterol Disord. 2004; 4 Suppl 1-21[PubMed]
  • 31. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004; 32(8): 493-5[DOI][PubMed]
  • 32. Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran. Hepat Mon. 2013; 13(12)[DOI][PubMed]
  • 33. Akhtar S, Moatter T, Azam SI, Rahbar MH, Adil S. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. J Viral Hepat. 2002; 9(4): 309-14[PubMed]
  • 34. Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VG, Arankalle VA. Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol. 2003; 41(11): 5240-4[PubMed]
  • 35. Singh S, Malhotra V, Sarin SK. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res. 2004; 119(4): 145-8[PubMed]
  • 36. Zhang L, Chen Z, Cao Y, Yu J, Li G, Yu W, et al. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol. 2004; 78(24): 13591-9[DOI][PubMed]
  • 37. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol. 2005; 75(4): 538-49[DOI][PubMed]
  • 38. Mohsen AH, Trent HCVSG. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut. 2001; 48(5): 707-13[PubMed]
  • 39. Thomson BJ, Finch RG. Hepatitis C virus infection. Clin Microbiol Infect. 2005; 11(2): 86-94[DOI][PubMed]
  • 40. Gonzaga RM, Rodart IF, Reis MG, Ramalho Neto CE, Silva DW. Distribution of Hepatitis C virus (HCV) genotypes in seropositive patients in the state of Alagoas, Brazil. Braz J Microbiol. 2008; 39(4): 644-7[DOI][PubMed]
  • 41. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis. 2006; 10(4): 272-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments